Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPR | P35270 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22206926 | 0.77 | PTGS2 (0.33) | ALDH1A1PTGS2MAPK1 | |
| SCHEMBL29284672 | 0.72 | PTGS2 (0.30) | PTGS2MAPK1 | |
| SCHEMBL13732345 | 0.71 | KMT2A (0.38) | SPR | |
| SCHEMBL12447413 | 0.70 | MAPK1 (0.37) | ALDH1A1SMN1; SMN2PTGS2MAPK1 | |
| SCHEMBL3050197 | 0.70 | RAB9A (0.49) | ALDH1A1LMNATP53MAPTHTT | |
| SCHEMBL17995120 | 0.69 | TRPV4 (0.36) | ALDH1A1LMNATP53MAPTSMN1; SMN2 | |
| SCHEMBL6052216 | 0.67 | CCR1 (0.51) | ALDH1A1MAPTSMN1; SMN2PTGS2MAPK1 | |
| SCHEMBL32683713 | 0.66 | KDM4E (0.42) | SPRALDH1A1MAPTSMN1; SMN2HSD17B10 | |
| SCHEMBL6156185 | 0.66 | LMNA (0.37) | ALDH1A1LMNASMN1; SMN2PTGS2MAPK1 | |
| SCHEMBL939312 | 0.65 | MAPT (0.41) | ALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2699563-B3 | NOVEL PESTICIDAL PYRAZOLE COMPOUNDS | BASF SE (DE) | 2024-06-12 | — | — | EP | disclosed |
| US-9439427-B2 | Pesticidal pyrazole compounds | BASF SE (DE) | 2016-09-13 | — | — | US | disclosed |
| EP-2699563-B1 | NOVEL PESTICIDAL PYRAZOLE COMPOUNDS | BASF SE (DE) | 2016-04-06 | — | — | EP | disclosed |
| US-20160050927-A1 | Novel pesticidal pyrazole compounds | BASF SE (DE) | 2016-02-25 | — | — | US | disclosed |
| US-9198422-B2 | Pesticidal pyrazole compounds | BASF SE (DE) | 2015-12-01 | — | — | US | disclosed |
| EP-2699563-A1 | NOVEL PESTICIDAL PYRAZOLE COMPOUNDS | BASF SE (DE) | 2014-02-26 | — | — | EP | disclosed |
| US-20140045690-A1 | Novel Pesticidal Pyrazole Compounds | BASF SE (DE) | 2014-02-13 | — | — | US | disclosed |
| WO-2012143317-A1 | NOVEL PESTICIDAL PYRAZOLE COMPOUNDS | BASF SE (DE) | 2012-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160050927-A1 | Novel pesticidal pyrazole compounds | CYP51A1, PKM, NOTUM | SPR 1548/4885ALDH1A1 1402/4885LMNA 4379/4885 |
| US-20140045690-A1 | Novel Pesticidal Pyrazole Compounds | CYP51A1, PKM, NOTUM | SPR 1548/4885ALDH1A1 1402/4885LMNA 4379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.